Search for: "Does 1-35" Results 521 - 540 of 9,553
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Dec 2021, 5:01 am by Emily Dai
However, since D.C. is not a state and does not have a governor, the president has the authority to activate the DCNG. [read post]
2 Jul 2013, 7:32 am by Lawrence B. Ebert
Patent No. 7,287,109 (the ’109 Patent) under 35 U.S.C. [read post]
11 Mar 2019, 9:35 pm by Lawrence B. Ebert
” In re Gleave, 560F.3d 1331, 1334–35 (Fed. [read post]
13 Sep 2023, 12:59 am by Rose Hughes
Cir. 2018), obviousness-type double patenting does not invalidate a patent that has a later expiry date due to PTE (35 U.S.C. [read post]
4 Jan 2007, 5:00 am
The Military Times did report that 35% of respondents said they were Protestant, 29% were Catholic, 7% were Evangelical Christian, 2% were Mormon, 1% were Jewish, 0% were Muslim, 13% were Other, and 12% had No Preference. [read post]
13 Feb 2008, 7:00 pm
  The judge reasoned that § 3553(a) is mandatory, without providing any exception for resentencings under Rule 35(b); the plain wording of Rule 35(b)(1) does not preclude considering other factors; the advisory committee notes to Rule 35(b)(1) support the conclusion; in applying Rule 35(b)(1), courts are to look for guidance to cases applying 5K1.1, which, as noted above, in this circuit apply all … [read post]
14 Jul 2014, 11:28 am
" Practice Tip #2: The FDA's ANDA process for generic drugs has been abbreviated such that, in general, the generic drug seeking approval does not require pre-clinical (animal and in vitro) testing. [read post]
9 Feb 2012, 7:23 am by Blaine T. Bettinger
Nash, On the Ownership of Academic Presentations: The Evolution of California Education Code Sections 66450-66452, 35 McGeorge L. [read post]
9 Feb 2012, 7:23 am by Blaine T. Bettinger
Nash, On the Ownership of Academic Presentations: The Evolution of California Education Code Sections 66450-66452, 35 McGeorge L. [read post]
7 Aug 2012, 7:43 pm by FDABlog HPM
§ 271(e)(1) “does not apply to information that may be routinely reported to the FDA, long after marketing approval has been obtained. [read post]
31 Oct 2012, 11:11 am by Jason Byrne
  Additionally, MCL 205.22 requires that an appeal of an assessment be brought within 35 days of that assessment, and MCL 205.28(1) requires service of that assessment upon the taxpayer. [read post]
11 Oct 2016, 8:10 am
In that respect, the court noted (as also previously stated by the EUIPO) that, according to settled case-law, the application of Article 7(1)(c) of the EUTMR does not depend on the existence of a real, current or serious need to leave a sign free. [read post]